Skip to main content

Main menu

  • HOME
  • LATEST ARTICLES
  • ALL ISSUES
  • AUTHORS & REVIEWERS
  • RESOURCES
    • About BJGP Open
    • BJGP Open Accessibility Statement
    • Editorial Board
    • Editorial Fellowships
    • Audio Abstracts
    • eLetters
    • Alerts
    • BJGP Life
    • Research into Publication Science
    • Advertising
    • Contact
  • SPECIAL ISSUES
    • Artificial Intelligence in Primary Care: call for articles
    • Social Care Integration with Primary Care: call for articles
    • Special issue: Telehealth
    • Special issue: Race and Racism in Primary Care
    • Special issue: COVID-19 and Primary Care
    • Past research calls
    • Top 10 Research Articles of the Year
  • BJGP CONFERENCE →
  • RCGP
    • British Journal of General Practice
    • BJGP for RCGP members
    • RCGP eLearning
    • InnovAIT Journal
    • Jobs and careers

User menu

  • Alerts

Search

  • Advanced search
Intended for Healthcare Professionals
BJGP Open
  • RCGP
    • British Journal of General Practice
    • BJGP for RCGP members
    • RCGP eLearning
    • InnovAIT Journal
    • Jobs and careers
  • Subscriptions
  • Alerts
  • Log in
  • Follow BJGP Open on Instagram
  • Visit bjgp open on Bluesky
  • Blog
Intended for Healthcare Professionals
BJGP Open

Advanced Search

  • HOME
  • LATEST ARTICLES
  • ALL ISSUES
  • AUTHORS & REVIEWERS
  • RESOURCES
    • About BJGP Open
    • BJGP Open Accessibility Statement
    • Editorial Board
    • Editorial Fellowships
    • Audio Abstracts
    • eLetters
    • Alerts
    • BJGP Life
    • Research into Publication Science
    • Advertising
    • Contact
  • SPECIAL ISSUES
    • Artificial Intelligence in Primary Care: call for articles
    • Social Care Integration with Primary Care: call for articles
    • Special issue: Telehealth
    • Special issue: Race and Racism in Primary Care
    • Special issue: COVID-19 and Primary Care
    • Past research calls
    • Top 10 Research Articles of the Year
  • BJGP CONFERENCE →
Protocol

Estimating the burden of vaccine-preventable lower respiratory tract disease in UK primary care: protocol for a prospective surveillance study (AvonCAP GP2)

Polly Duncan, Ruth Mears, Elizabeth Begier, Sanaz Rouhbakhsh Halvaei, Jo Southern, Siân Bodfel Porter, Robin Hubler, Glenda Oben, George Qian, Maria Lahuerta, Tim Davis, James Campling, Shoba Dawson, Hannah Christensen, Jennifer Oliver, Begonia Morales-Aza, Kaijie Pan, Sharon Gray, Catherine Hyams, Leon Danon, Bradford D Gessner, Adam Finn, Alastair D Hay and AvonCAP GP2 research group
BJGP Open 2024; 8 (4): BJGPO.2024.0129. DOI: https://doi.org/10.3399/BJGPO.2024.0129
Polly Duncan
1 Centre for Academic Primary Care, University of Bristol, Bristol, UK
2 Bristol Vaccine Centre, Schools of Population Health Science and Cellular and Molecular Medicine, University of Bristol, Bristol, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Polly Duncan
  • For correspondence: polly.duncan{at}bristol.ac.uk
Ruth Mears
1 Centre for Academic Primary Care, University of Bristol, Bristol, UK
2 Bristol Vaccine Centre, Schools of Population Health Science and Cellular and Molecular Medicine, University of Bristol, Bristol, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elizabeth Begier
3 Global Respiratory Vaccines, Medical & Scientific Affairs, Pfizer Inc, Collegeville, PA, US
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sanaz Rouhbakhsh Halvaei
2 Bristol Vaccine Centre, Schools of Population Health Science and Cellular and Molecular Medicine, University of Bristol, Bristol, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jo Southern
4 Evidence Generation, Pfizer Inc, Collegeville, PA, US
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Siân Bodfel Porter
2 Bristol Vaccine Centre, Schools of Population Health Science and Cellular and Molecular Medicine, University of Bristol, Bristol, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robin Hubler
4 Evidence Generation, Pfizer Inc, Collegeville, PA, US
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Glenda Oben
2 Bristol Vaccine Centre, Schools of Population Health Science and Cellular and Molecular Medicine, University of Bristol, Bristol, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
George Qian
2 Bristol Vaccine Centre, Schools of Population Health Science and Cellular and Molecular Medicine, University of Bristol, Bristol, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria Lahuerta
3 Global Respiratory Vaccines, Medical & Scientific Affairs, Pfizer Inc, Collegeville, PA, US
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tim Davis
1 Centre for Academic Primary Care, University of Bristol, Bristol, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James Campling
5 Vaccines Medical Affairs, Pfizer Ltd, Tadworth, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shoba Dawson
1 Centre for Academic Primary Care, University of Bristol, Bristol, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hannah Christensen
2 Bristol Vaccine Centre, Schools of Population Health Science and Cellular and Molecular Medicine, University of Bristol, Bristol, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jennifer Oliver
2 Bristol Vaccine Centre, Schools of Population Health Science and Cellular and Molecular Medicine, University of Bristol, Bristol, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Begonia Morales-Aza
2 Bristol Vaccine Centre, Schools of Population Health Science and Cellular and Molecular Medicine, University of Bristol, Bristol, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kaijie Pan
6 EvGen Statistics, Pfizer Research and Development, Pfizer Inc, Collegeville, PA, US
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sharon Gray
4 Evidence Generation, Pfizer Inc, Collegeville, PA, US
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Catherine Hyams
2 Bristol Vaccine Centre, Schools of Population Health Science and Cellular and Molecular Medicine, University of Bristol, Bristol, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leon Danon
7 School of Engineering Mathematics and Technology, University of Bristol, Bristol, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bradford D Gessner
3 Global Respiratory Vaccines, Medical & Scientific Affairs, Pfizer Inc, Collegeville, PA, US
8 West of England NIHR Clinical Research Network, Bristol, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adam Finn
2 Bristol Vaccine Centre, Schools of Population Health Science and Cellular and Molecular Medicine, University of Bristol, Bristol, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alastair D Hay
1 Centre for Academic Primary Care, University of Bristol, Bristol, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info
  • eLetters
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1. Study flow diagram

    aFor adults who present to the emergency department, they will only be eligible if they are not admitted to hospital. bThe research team will run a search of the electronic GP records at least twice a day to identify adults with aLRTD diagnosis, symptoms, clinical findings, and/or prescribed antibiotics. They will manually review the consultation notes, including free text, and contact the patient to assess eligibility. cWe have approval from the Confidentiality Advisory Group to include specific groups of patients in the surveillance arm without consent, including those we are unable to contact (at least three failed contact attempts over ≥24 hours) and patients at the end of life. If a patient lacks capacity to provide consent (for example, owing to cognitive impairment or dementia), the research team will attempt to contact a family member, friend, or unpaid carer of the patient (that is, a personal consultee) to discuss the patient’s willingness to take part. If they are unable to contact a personal consultee or if the person contacted does not want to take on the role of personal consultee, the research practitioner or nurse will attempt to identify and contact a nominated consultee. ‘Medical data’ refers to routinely collected data within the electronic GP records. dIf a patient declines consent (or other specified cohorts of patient), descriptive data will be collected, including: screening ID, anonymous encrypted NHS number, date of eligible condition, reasons for declining to participate, eligibility, qualifying condition, severity of illness, gender, age, deprivation decile, ethnicity, whether they reside in a care home or not, whether they require a translator (and if so what language), category of patient presentation (out-of-hours GP, in-hours GP, or emergency department), whether they die within 30 days of their appointment, and, if so, whether their death was related to their qualifying illness. eDaily symptom diary until recovery from illness or for up to 28 days. fNose and/or throat, saliva, and urine samples collected on day 1. gFollow-up survey (on quality of life, time off work, and recovery) at 6 weeks, 8 weeks, 3 months, 4 months, 5 months, 6 months, 9 months, and 12 months (until fully recovered from illness). aLRTD = acute lower respiratory tract disease.

Tables

  • Figures
    • View popup
    Table 1. Summary of variables to be collected
    Descriptive dataset arm
    Sociodemographics
    • Age

    • Gender

    • Deprivation decile

    • Ethnicity (White and Black, Asian, and Minority ethnic)

    • Care home resident

    • Translator required (if so, what language)

    Illness episode
    • Clinical diagnosis

    • Severity of acute illness (reported by clinician)

    • Date of eligible condition

    • Category of patient presentation (in-hours or out-of-hours primary care, or emergency department)

    • Date of death and whether the death was related to the qualifying illness

    Surveillance arm (data collected in addition to descriptive dataset arm variables)
    General health
    • Long-term conditionsa

    • Smoking status

    • Alcohol status

    • Pregnancy status

    • Rockwood Frailty Scale score

    • Risk factors for pneumococcal infection

    Vaccinations
    • Influenza

    • SARS-CoV-2

    • Pneumococcal

    Symptoms
    • Upper and lower respiratory symptoms

    • Heart failure symptoms

    Complications
    • Acute renal failure, liver dysfunction, myocardial infarction, new atrial fibrillation, stroke, transient ischaemic attack, deep vein thrombosis, pulmonary embolus, new or worsening of congestive heart failure, fall, reduced mobility, and/or increased care requirements

    Primary care attendances
    • Number and type of primary care appointments (in-hour and out-of-hours)

    Secondary care attendances
    • Hospital admission (length of stay, treatment, and outcome)

    • Outpatient appointments

    Use of other healthcare services
    • Emergency department attendances

    • 111 calls

    • Ambulance attendances

    Investigations
    • Radiology (for example, CXR and CT scan)

    • Microbiology

    • SARS-CoV-2 test results

    Treatment
    • Antibiotics

    • Steroids

    • Inhalers

    • Diuretics

    • Antivirals

    Vital status
    • Date of death (if occurring within 30 days of index consultation date or for up to a maximum of 12 months for those who have not recovered at 28 days)

    Embedded diagnostic arm (data collected in addition to descriptive dataset and surveillance variables)
    Surveys
    • EQ-5D-5L (today, worst day of illness, and before this illness)

    • Number of children and adults living in the household

    • Employed as a healthcare worker

    Samples
    • Nose and/or throat swab

    • Saliva

    • Urine

    Physical examination
    • Confusion screenb

    • Temperatureb

    • Oxygen saturationb

    • Heart rateb

    • Respiratory rateb

    • Blood pressureb

    • Weight

    • Height

    • Body mass index

    Symptom diary (until fully recovered from illness for up to 28 days)
    • Presence and severity of symptoms17 (completed daily)

    • EQ-5D-5L (completed weekly)

    • Time off work (completed weekly)

    • aLong-term conditions from the 20 medical conditions included in the Cambridge Multimorbidity Score19 and the Charlson Comorbidity Index score.20 bExamination findings collected from February 2022–October 2023 only. CT = computed tomography. CXR = chest radiography.

Supplementary Data

  • PD_10.3399BJGPO.2024.0129_supp_v2.pdf -


    Supplementary material is not copyedited or typeset, and is published as supplied by the author(s). The author(s) retain(s) responsibility for its accuracy. 

Back to top
Previous ArticleNext Article

In this issue

BJGP Open
Vol. 8, Issue 4
December 2024
  • Table of Contents
  • Index by author
Download PDF
Download PowerPoint
Email Article

Thank you for recommending BJGP Open.

NOTE: We only request your email address so that the person to whom you are recommending the page knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Estimating the burden of vaccine-preventable lower respiratory tract disease in UK primary care: protocol for a prospective surveillance study (AvonCAP GP2)
(Your Name) has forwarded a page to you from BJGP Open
(Your Name) thought you would like to see this page from BJGP Open.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Estimating the burden of vaccine-preventable lower respiratory tract disease in UK primary care: protocol for a prospective surveillance study (AvonCAP GP2)
Polly Duncan, Ruth Mears, Elizabeth Begier, Sanaz Rouhbakhsh Halvaei, Jo Southern, Siân Bodfel Porter, Robin Hubler, Glenda Oben, George Qian, Maria Lahuerta, Tim Davis, James Campling, Shoba Dawson, Hannah Christensen, Jennifer Oliver, Begonia Morales-Aza, Kaijie Pan, Sharon Gray, Catherine Hyams, Leon Danon, Bradford D Gessner, Adam Finn, Alastair D Hay, AvonCAP GP2 research group
BJGP Open 2024; 8 (4): BJGPO.2024.0129. DOI: 10.3399/BJGPO.2024.0129

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Estimating the burden of vaccine-preventable lower respiratory tract disease in UK primary care: protocol for a prospective surveillance study (AvonCAP GP2)
Polly Duncan, Ruth Mears, Elizabeth Begier, Sanaz Rouhbakhsh Halvaei, Jo Southern, Siân Bodfel Porter, Robin Hubler, Glenda Oben, George Qian, Maria Lahuerta, Tim Davis, James Campling, Shoba Dawson, Hannah Christensen, Jennifer Oliver, Begonia Morales-Aza, Kaijie Pan, Sharon Gray, Catherine Hyams, Leon Danon, Bradford D Gessner, Adam Finn, Alastair D Hay, AvonCAP GP2 research group
BJGP Open 2024; 8 (4): BJGPO.2024.0129. DOI: 10.3399/BJGPO.2024.0129
del.icio.us logo Facebook logo Mendeley logo Bluesky logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
  • Mendeley logo Mendeley

Jump to section

  • Top
  • Article
    • Abstract
    • How this fits in
    • Introduction
    • Method
    • Discussion
    • Notes
    • References
  • Figures & Data
  • Info
  • eLetters
  • PDF

Keywords

  • primary health care
  • lower respiratory tract infection
  • respiratory tract diseases
  • respiratory syncytial viruses

More in this TOC Section

  • Personalising renal function monitoring and interventions in people living with heart failure: a protocol for co-designing a care pathway in the RENAL-HF programme
  • Realist evaluation of multi-professional advanced practice in primary care (REMAP): study protocol
  • Enhancing understanding of interventions to increase relational continuity in general practice: a realist review protocol
Show more Protocol

Related Articles

Cited By...

Intended for Healthcare Professionals

 
 

British Journal of General Practice

NAVIGATE

  • Home
  • Latest articles
  • Authors & reviewers
  • Accessibility statement

RCGP

  • British Journal of General Practice
  • BJGP for RCGP members
  • RCGP eLearning
  • InnovAiT Journal
  • Jobs and careers

MY ACCOUNT

  • RCGP members' login
  • Terms and conditions

NEWS AND UPDATES

  • About BJGP Open
  • Alerts
  • RSS feeds
  • Facebook
  • Twitter

AUTHORS & REVIEWERS

  • Submit an article
  • Writing for BJGP Open: research
  • Writing for BJGP Open: practice & policy
  • BJGP Open editorial process & policies
  • BJGP Open ethical guidelines
  • Peer review for BJGP Open

CUSTOMER SERVICES

  • Advertising
  • Open access licence

CONTRIBUTE

  • BJGP Life
  • eLetters
  • Feedback

CONTACT US

BJGP Open Journal Office
RCGP
30 Euston Square
London NW1 2FB
Tel: +44 (0)20 3188 7400
Email: bjgpopen@rcgp.org.uk

BJGP Open is an editorially-independent publication of the Royal College of General Practitioners

© 2026 BJGP Open

Online ISSN: 2398-3795